JBM (Healthcare) Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1090B1077
HKD
2.65
0.07 (2.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
782.29
648.41
520.32
406.14
397.16
381.54
307.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
782.29
648.41
520.32
406.14
397.16
381.54
307.51
Raw Material Cost
368.58
329.00
332.40
263.84
216.22
211.43
149.84
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
99.46
92.76
89.02
70.99
74.20
67.30
48.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.46
8.50
8.21
6.41
7.41
0.84
1.39
Selling and Distribution Expenses
185.74
161.55
120.15
105.94
110.03
119.17
95.16
Other Expenses
-10.39
-10.13
-9.72
-7.74
-8.16
-6.81
-4.95
Total Expenditure (Excl Depreciation)
554.33
490.55
452.55
369.78
326.25
330.59
245.23
Operating Profit (PBDIT) excl Other Income
228
157.89999999999998
67.8
36.4
70.9
50.9
62.300000000000004
Other Income
18.10
16.34
14.18
5.08
1.25
8.09
4.24
Operating Profit (PBDIT)
298.35
220.73
125.58
89.23
115.77
94.90
96.20
Interest
4.46
8.50
8.21
6.41
7.41
0.84
1.39
Exceptional Items
0.00
0.00
5.09
-2.50
-21.89
-7.19
0.00
Gross Profit (PBDT)
413.71
319.42
187.92
142.30
180.94
170.12
157.68
Depreciation
52.28
46.52
43.63
47.78
43.60
35.86
29.68
Profit Before Tax
241.60
165.71
78.83
32.54
42.87
51.00
65.13
Tax
38.98
27.68
13.57
7.42
11.06
9.67
10.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
197.26
130.46
57.09
24.62
22.60
41.02
52.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
197.26
130.46
57.09
24.62
22.60
41.02
52.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.43
6.75
6.24
-1.29
8.02
3.27
6.81
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.69
137.21
63.33
23.33
30.62
44.30
59.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.0
0.0
Reserves
1,082.02
970.68
985.51
929.20
904.71
657.33
147.64
Earnings per share (EPS)
0.24
0.15
0.06
0.03
0.03
0.0
0.0
Diluted Earnings per share
0.24
0.15
0.06
0.03
0.03
0.0
0.0
Operating Profit Margin (Excl OI)
29.14%
24.35%
13.02%
8.95%
17.85%
13.35%
20.25%
Gross Profit Margin
37.57%
32.73%
23.54%
19.78%
21.77%
22.77%
30.83%
PAT Margin
25.22%
20.12%
10.97%
6.06%
5.69%
10.75%
17.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 20.65% vs 24.62% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 47.74% vs 116.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 37.08% vs 83.48% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -47.06% vs 3.66% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of JBM (Healthcare) Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
782.29
1,576.90
-794.61
-50.39%
Other Operating Income
0.00
0.00
0.00
Total Operating income
782.29
1,576.90
-794.61
-50.39%
Raw Material Cost
368.58
883.96
-515.38
-58.30%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
99.46
473.05
-373.59
-78.97%
Power Cost
0
0
0.00
Manufacturing Expenses
4.46
41.37
-36.91
-89.22%
Selling and Distribution Expenses
185.74
322.00
-136.26
-42.32%
Other Expenses
-10.39
-51.22
40.83
79.71%
Total Expenditure (Excl Depreciation)
554.33
1,208.19
-653.86
-54.12%
Operating Profit (PBDIT) excl Other Income
227.97
368.70
-140.73
-38.17%
Other Income
18.10
77.63
-59.53
-76.68%
Operating Profit (PBDIT)
298.35
590.20
-291.85
-49.45%
Interest
4.46
41.37
-36.91
-89.22%
Exceptional Items
0.00
-31.73
31.73
100.00%
Gross Profit (PBDT)
413.71
692.94
-279.23
-40.30%
Depreciation
52.28
143.87
-91.59
-63.66%
Profit Before Tax
241.60
373.23
-131.63
-35.27%
Tax
38.98
72.79
-33.81
-46.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
197.26
300.83
-103.57
-34.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
197.26
300.83
-103.57
-34.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
5.43
0.00
5.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.69
300.83
-98.14
-32.62%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
1,082.02
2,453.22
-1,371.20
-55.89%
Earnings per share (EPS)
0.24
0.15
0.09
60.00%
Diluted Earnings per share
0.24
0.15
0.09
60.00%
Operating Profit Margin (Excl OI)
29.14%
23.38%
0.00
5.76%
Gross Profit Margin
37.57%
32.79%
0.00
4.78%
PAT Margin
25.22%
19.08%
0.00
6.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 78.23 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 20.65% vs 24.62% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 20.27 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 47.74% vs 116.75% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.02 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 37.08% vs 83.48% in Mar 2024

Annual - Interest
Interest 0.45 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -47.06% vs 3.66% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.14%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024